Geode Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.33M Buy
6,718,879
+401,637
+6% +$498K ﹤0.01% 2475
2025
Q1
$7.46M Buy
6,317,242
+54,317
+0.9% +$64.1K ﹤0.01% 2460
2024
Q4
$11.5M Sell
6,262,925
-64,981
-1% -$119K ﹤0.01% 2285
2024
Q3
$10.8M Buy
6,327,906
+225,034
+4% +$383K ﹤0.01% 2332
2024
Q2
$8.36M Buy
6,102,872
+460,093
+8% +$630K ﹤0.01% 2434
2024
Q1
$21.2M Buy
5,642,779
+126,393
+2% +$474K ﹤0.01% 1887
2023
Q4
$54.1M Buy
5,516,386
+412,150
+8% +$4.04M 0.01% 1297
2023
Q3
$42.6M Buy
5,104,236
+182,428
+4% +$1.52M 0.01% 1330
2023
Q2
$65.5M Buy
4,921,808
+190,699
+4% +$2.54M 0.01% 1060
2023
Q1
$54.8M Buy
4,731,109
+561,499
+13% +$6.5M 0.01% 1123
2022
Q4
$34.1M Buy
4,169,610
+140,672
+3% +$1.15M ﹤0.01% 1407
2022
Q3
$23.4M Sell
4,028,938
-54,359
-1% -$316K ﹤0.01% 1619
2022
Q2
$18M Buy
4,083,297
+240,733
+6% +$1.06M ﹤0.01% 1836
2022
Q1
$35M Buy
3,842,564
+138,571
+4% +$1.26M ﹤0.01% 1503
2021
Q4
$75.8M Buy
3,703,993
+218,252
+6% +$4.47M 0.01% 992
2021
Q3
$89.1M Sell
3,485,741
-6,305
-0.2% -$161K 0.01% 873
2021
Q2
$122M Buy
3,492,046
+237,209
+7% +$8.3M 0.02% 700
2021
Q1
$108M Buy
3,254,837
+276,228
+9% +$9.2M 0.02% 720
2020
Q4
$77.3M Buy
2,978,609
+470,245
+19% +$12.2M 0.01% 820
2020
Q3
$24.8M Buy
2,508,364
+287,765
+13% +$2.84M ﹤0.01% 1376
2020
Q2
$7.66M Buy
2,220,599
+70,238
+3% +$242K ﹤0.01% 2091
2020
Q1
$6.58M Buy
2,150,361
+125,953
+6% +$385K ﹤0.01% 1989
2019
Q4
$10.4M Buy
2,024,408
+117,342
+6% +$603K ﹤0.01% 1986
2019
Q3
$9.84M Sell
1,907,066
-38,100
-2% -$197K ﹤0.01% 1942
2019
Q2
$11.8M Buy
1,945,166
+194,655
+11% +$1.18M ﹤0.01% 1830
2019
Q1
$12.7M Buy
1,750,511
+177,030
+11% +$1.28M ﹤0.01% 1739
2018
Q4
$11.6M Buy
1,573,481
+156,404
+11% +$1.16M ﹤0.01% 1686
2018
Q3
$7.67M Buy
1,417,077
+251,500
+22% +$1.36M ﹤0.01% 2098
2018
Q2
$4.14M Buy
1,165,577
+153,641
+15% +$545K ﹤0.01% 2430
2018
Q1
$2.07M Buy
1,011,936
+79,361
+9% +$163K ﹤0.01% 2733
2017
Q4
$2.46M Buy
932,575
+57,374
+7% +$151K ﹤0.01% 2633
2017
Q3
$4.59M Buy
875,201
+211,646
+32% +$1.11M ﹤0.01% 2253
2017
Q2
$2.36M Buy
663,555
+7,352
+1% +$26.2K ﹤0.01% 2637
2017
Q1
$3.39M Buy
656,203
+67,069
+11% +$347K ﹤0.01% 2351
2016
Q4
$2.24M Buy
589,134
+14,177
+2% +$53.9K ﹤0.01% 2569
2016
Q3
$5.15M Buy
574,957
+87,690
+18% +$786K ﹤0.01% 1954
2016
Q2
$3.43M Buy
487,267
+14,167
+3% +$99.6K ﹤0.01% 2136
2016
Q1
$4.02K Buy
473,100
+53,943
+13% +$458 ﹤0.01% 2007
2015
Q4
$5.5M Buy
419,157
+11,597
+3% +$152K ﹤0.01% 1805
2015
Q3
$1.49M Buy
407,560
+15,339
+4% +$56.1K ﹤0.01% 2631
2015
Q2
$2.26M Buy
392,221
+27,124
+7% +$156K ﹤0.01% 2418
2015
Q1
$2.13M Buy
365,097
+22,072
+6% +$129K ﹤0.01% 2401
2014
Q4
$2.69M Buy
343,025
+40,120
+13% +$315K ﹤0.01% 2240
2014
Q3
$1.49M Buy
302,905
+31,752
+12% +$156K ﹤0.01% 2551
2014
Q2
$1.68M Buy
271,153
+6,716
+3% +$41.5K ﹤0.01% 2485
2014
Q1
$1.41M Buy
264,437
+32,058
+14% +$171K ﹤0.01% 2561
2013
Q4
$1.22M Buy
232,379
+13,258
+6% +$69.3K ﹤0.01% 2595
2013
Q3
$1.21M Buy
219,121
+55,003
+34% +$304K ﹤0.01% 2490
2013
Q2
$414K Buy
+164,118
New +$414K ﹤0.01% 2962